Summary of Significant Accounting Policies - Segments (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2022 USD ($)	Mar. 31, 2021 USD ($)	Mar. 31, 2022 USD ($) segment	Mar. 31, 2021 USD ($)
Medical Indication Information
Number of reportable segments | segment			1
Total net sales	$ 78,357	$ 112,370	$ 266,390	$ 372,769
Analgesic
Medical Indication Information
Total net sales	3,292	3,836	12,525	10,528
Anti-Psychosis
Medical Indication Information
Total net sales	3,346	11,678	9,156	38,023
Cardiovascular
Medical Indication Information
Total net sales	9,468	16,573	33,321	52,623
Central Nervous System
Medical Indication Information
Total net sales	15,177	24,509	60,302	71,648
Endocrinology
Medical Indication Information
Total net sales	6,792	6,822	22,934	19,551
Gastrointestinal
Medical Indication Information
Total net sales	11,709	16,817	40,972	52,492
Infectious Disease
Medical Indication Information
Total net sales	5,438	10,610	24,473	55,586
Migraine
Medical Indication Information
Total net sales	3,507	5,169	12,638	20,942
Respiratory/Allergy/Cough/Cold
Medical Indication Information
Total net sales	2,309	2,548	7,291	6,241
Urinary
Medical Indication Information
Total net sales	827	1,566	3,167	4,385
Other
Medical Indication Information
Total net sales	13,873	8,617	32,160	24,661
Contract manufacturing revenue
Medical Indication Information
Total net sales	$ 2,619	$ 3,625	$ 7,451	$ 16,089